Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Surgically-removed tumor specimens can help quickly evaluate cancer drug efficacy

Genetic differences can affect the susceptibility of cancer cells to different drugs. In a new Molecular Oncology study, investigators show that surgically-removed breast and prostate tumor specimens can be used to rapidly screen different drugs to see which ones most effectively target an individual's cancer cells.

22 Aug 2018

Researchers identify genes responsible for inherited breast cancer in Nigerian women

For the first time, DNA contributed by Sub-Saharan African women has been thoroughly evaluated with innovative genomics technology in an effort to understand the genetic bases for breast cancer in African populations.

22 Aug 2018

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Agilent Technologies Inc. today announced that the U.S. Food and Drug Administration has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma.

22 Aug 2018

National Foundation for Cancer Research receives Safeway Foundation grant

The National Foundation for Cancer Research is one of 13 local and regional organizations to be the recipient of a grant by Safeway Foundation supporting cancer research and treatment efforts.

21 Aug 2018

New study describes effect of radiation exposure on hormone deficiency in children

In a new study, University of Cincinnati researchers, in collaboration with Massachusetts General Hospital, have detailed the effect of radiation exposure on the development of hormone deficiency in pediatric and young adult patients treated for brain tumors.

21 Aug 2018

CURE Media Group welcomes CancerCare to Strategic Alliance Partnership Program

CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.

21 Aug 2018

After-hours telemedicine can lead to fewer hospitalizations and more savings

When doctors could be reached via telemedicine to decide whether a patient in a skilled nursing facility (SNF) should be hospitalized, 29% of the patients evaluated avoided a hospital visit, saving $1.55 million over the course of a year, according to results reported in the current issue of The American Journal of Managed Care.

20 Aug 2018

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.

20 Aug 2018

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

20 Aug 2018

Infection rates of high risk oral HPV in England found to be lower than expected

Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

20 Aug 2018

AJMC addresses role of community pharmacies in boosting adult vaccination rates

A recent publication from The American Journal of Managed Care, the leading peer-reviewed journal dedicated to issues in managed care, addresses the role of community pharmacies in boosting adult vaccination rates in the United States.

17 Aug 2018

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

When enrolled in a cancer clinical trial, the differences in survival rates between rural and urban patients are significantly reduced, SWOG study results show.

17 Aug 2018

Innovative platform developed to destroy cancer cells

The new treatment will serve as both diagnosis and treatment of malignant tumors. This breakthrough in the technologies of cancer diagnosis and treatment was made by an interdisciplinary Russian-German collaboration of chemists, physicists, and biologists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Research Medical University (RNRMU), and the University of Duisburg-Essen (Germany).

17 Aug 2018

Valley Hospital achieves Magnet recognition for fourth consecutive time

The Valley Hospital is proud to announce that it has achieved the prestigious Magnet recognition - the highest national honor for professional nursing practice - for a fourth consecutive time.

17 Aug 2018

Trial shows PARP inhibitor as novel treatment option for patients with advanced breast cancers

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

16 Aug 2018

Ablating the mutant p53 gene in mice with colorectal cancer inhibits tumor growth

By genetically manipulating and removing the most common mutant form of the p53 gene that promotes colorectal cancer in humans, an international team of scientists demonstrated that this therapy reduces tumor growth and tissue invasion.

15 Aug 2018

Innovative oncofertility program launched by RMA of New York and Mount Sinai Health System

Reproductive Medicine Associates of New York, a Manhattan-based fertility center, and the Mount Sinai Health System have launched an innovative, integrated oncofertility program at The Blavatnik Family – Chelsea Medical Center at Mount Sinai to provide individuals and couples the benefit of advanced medical technologies to help with someday building their families.

15 Aug 2018

Scientists explore ways for drug therapies to reach deadly brain tumors

The blood-brain barrier is a specialized network of vascular and brain cells that acts as the brain's security system, helping to safeguard the brain and regulate the flow of substances into and out of it.

15 Aug 2018

Clinical study suggests new treatment direction for head and neck cancer in heavy smokers

Patients with a greater than 10 pack/year history of smoking tend to develop an especially dangerous form of head and neck squamous cell cancer for which prognosis remains poor and treatments have changed little during the past two decades.

14 Aug 2018

Study identifies potential guidance to treat gastric cancer patients

Researchers from Wake Forest Baptist Medical Center and Tianjin Medical University Cancer Institute and Hospital have discovered that gastric cancer tissue samples bearing mutation of a specific gene, MUC16, too are associated with higher tumor mutation loads.

14 Aug 2018

Oncology News and Research

Further Reading

Surgically-removed tumor specimens can help quickly evaluate cancer drug efficacy

Researchers identify genes responsible for inherited breast cancer in Nigerian women

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

National Foundation for Cancer Research receives Safeway Foundation grant

New study describes effect of radiation exposure on hormone deficiency in children

CURE Media Group welcomes CancerCare to Strategic Alliance Partnership Program

After-hours telemedicine can lead to fewer hospitalizations and more savings

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Infection rates of high risk oral HPV in England found to be lower than expected

AJMC addresses role of community pharmacies in boosting adult vaccination rates

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

Innovative platform developed to destroy cancer cells

Valley Hospital achieves Magnet recognition for fourth consecutive time

Trial shows PARP inhibitor as novel treatment option for patients with advanced breast cancers

Ablating the mutant p53 gene in mice with colorectal cancer inhibits tumor growth

Innovative oncofertility program launched by RMA of New York and Mount Sinai Health System

Scientists explore ways for drug therapies to reach deadly brain tumors

Clinical study suggests new treatment direction for head and neck cancer in heavy smokers

Study identifies potential guidance to treat gastric cancer patients

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News